share_log

AEON Biopharma Q3 2024 GAAP EPS $(0.16), Inline

Benzinga ·  Nov 14, 2024 05:14

AEON Biopharma (AMEX:AEON) reported quarterly losses of $(0.16) per share which met the analyst consensus estimate.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment